Auteur M. OLFSON

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Cannabis use and risk of psychiatric disorders: Prospective evidence from a US national longitudinal study

C. BLANCO ; D. S. HASIN ; M. M. WALL ; L. FLOREZ-SALAMANCA ; N. HOERTEL ; S. WANG ; B. T. KERRIDGE ; M. OLFSON | 2016
Dans JAMA Psychiatry (Vol.73, n°4, April 2016) Article : Périodique

Importance: With rising rates of marijuana use in the general population and an increasing number of states legalizing recreational marijuana use and authorizing medical marijuana programs, there are renewed clinical and policy concerns regardin[...]

Plus d'info

Ajouter à la sélection

Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients

R. K. ROSS ; E. V. NUNES ; M. OLFSON ; M. SHULMAN ; N. KRAWCZYK ; E. A. STUART ; K. E. RUDOLPH | 2024
Dans Addiction (Vol.119, n°11, November 2024) Article : Périodique

BACKGROUND AND AIMS: Extended-release naltrexone (XR-NTX) and sublingual buprenorphine (SL-BUP) are both approved for opioid use disorder (OUD) treatment in any medical setting. We aimed to compare the real-world effectiveness of XR-NTX and SL-B[...]

Plus d'info

Ajouter à la sélection

Lien externe

Is cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis

L. R. GORFINKEL ; M. STOHL ; E. GREENSTEIN ; E. AHARONOVICH ; M. OLFSON ; D. HASIN | 2021
Dans Addiction (Vol.116, n°5, May 2021) Article : Périodique

BACKGROUND AND AIMS: Ecological studies have suggested that Cannabis legalization might have led to a decrease in opioid overdose deaths. Such studies do not provide information about whether individuals are substituting Cannabis for opioids at [...]

Plus d'info

Ajouter à la sélection

Nicotine dependence and incident psychiatric disorders: prospective evidence from US national study

G. AIRAGNES ; M. SANCHEZ-RICO ; A. DEGUILHEM ; C. BLANCO ; M. OLFSON ; C. OUAZANA VEDRINES ; C. LEMOGNE ; F. LIMOSIN ; N. HOERTEL | 2025
Dans Molecular Psychiatry (Vol.30, n°3, March 2025) Article : Périodique

We examined the prospective associations between nicotine dependence and the likelihood of psychiatric and substance use disorders in the general adult population. Participants came from a nationally representative sample of US adults aged 18 ye[...]

Plus d'info

Ajouter à la sélection

Lien externe

Prevalence and treatment of mental disorders, 1990 to 2003

R. C. KESSLER ; DEMLER O. ; R. G. FRANK ; M. OLFSON ; H. A. PINCUS ; E. E. WALTERS ; P. WANG ; K. B. WELLS ; A. M. ZASLAVSKY | 2005
Dans New England Journal of Medicine (Vol.352, n°24, June 16, 2005) Article : Périodique

Background: Although the 1990s saw enormous change in the mental health care system in the United States, little is known about changes in the prevalence or rate of treatment of mental disorders. Methods: We examined trends in the prevalence and[...]

Plus d'info

Ajouter à la sélection

Lien externe

Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication

P. S. WANG ; M. LANE ; M. OLFSON ; H. A. PINCUS ; K. B. WELLS ; R. C. KESSLER | 2005
Périodique

BACKGROUND: Dramatic changes have occurred in mental health treatments during the past decade. Data on recent treatment patterns are needed to estimate the unmet need for services. OBJECTIVE: To provide data on patterns and predictors of 12-mont[...]

Plus d'info

Ajouter à la sélection

Use of marijuana exclusively for medical purposes

M. M. WALL ; J. LIU ; D. S. HASIN ; C. BLANCO ; M. OLFSON | 2019
Dans Drug and Alcohol Dependence (Vol.195, February 2019) Article : Périodique

Objectives: To characterize the socio-demographic characteristics, medical conditions, and psychiatric comorbidities of users of marijuana for medical and non-medical purposes. Methods: Data were from the National Epidemiological Survey on Alco[...]

Plus d'info

Ajouter à la sélection